CME Group Q3 2026 slides: record revenue, 13% earnings growth
CME Group reported record Q3 2026 revenue of $1.74B, up 13% YoY, with EPS of $3.02, beating estimates. Shares fell 1% premarket. Growth driven by global market volatility and product innovation. International ADV up 22% YoY. Management expects record full-year performance.
How this was made
The 30-second read
Why it matters
The results confirm CME's dominant market position but suggest limited short‑term upside as expectations were largely met.
Market read
Earnings beat with modest share dip; strong volume metrics may influence broader market sentiment on exchange stocks.
What to watch
Upcoming fee changes and cloud migration investments may drive longer‑term earnings growth beyond the quarter.
Background
CME Group's Q3 2026 earnings release highlighted record revenue, double‑digit growth across all segments, and continued international expansion.
Ticker impact
CME Group reported Q3 2026 earnings with record revenue of $1.74B and EPS $3.02, beating estimates.
likely slight pressure as market priced in strong results
Despite beating forecasts, the 1% pre‑market decline suggests investors had expectations already priced in, limiting upside.
Market effects
Strong volume growth across all asset classes may boost other exchange operators and related technology providers.
International trading volume surge highlights continued demand in APAC and EMEA, supporting regional brokers.
Record ADV and open interest reinforce CME's role as a key liquidity provider in global derivatives markets.
Counterpoint
The earnings beat could be a buying opportunity if the market overreacted to the modest pre‑market dip.
Key entities
- CompanyCME Group Inc.
Global derivatives exchange operator.

